INTELLIGENT LIVING APPLICATI (ILAG)

KYG4804S1012 - Common Stock

0.5625  0 (-0.6%)

After market: 0.551 -0.01 (-2.04%)

Fundamental Rating

2

Overall ILAG gets a fundamental rating of 2 out of 10. We evaluated ILAG against 43 industry peers in the Building Products industry. ILAG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ILAG does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

ILAG had negative earnings in the past year.
In the past year ILAG has reported a negative cash flow from operations.
ILAG had negative earnings in each of the past 5 years.
ILAG had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -22.40%, ILAG is doing worse than 93.02% of the companies in the same industry.
The Return On Equity of ILAG (-25.95%) is worse than 86.05% of its industry peers.
Industry RankSector Rank
ROA -22.4%
ROE -25.95%
ROIC N/A
ROA(3y)-11.54%
ROA(5y)-13.45%
ROE(3y)-24.45%
ROE(5y)-26.61%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 16.91%, ILAG is doing worse than 86.05% of the companies in the same industry.
In the last couple of years the Gross Margin of ILAG has grown nicely.
ILAG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.6%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

ILAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ILAG has about the same amount of shares outstanding.
ILAG has a better debt/assets ratio than last year.

2.2 Solvency

ILAG has an Altman-Z score of 2.35. This is not the best score and indicates that ILAG is in the grey zone with still only limited risk for bankruptcy at the moment.
ILAG's Altman-Z score of 2.35 is on the low side compared to the rest of the industry. ILAG is outperformed by 72.09% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that ILAG is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.02, ILAG belongs to the best of the industry, outperforming 81.40% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 2.35
ROIC/WACCN/A
WACC12.35%

2.3 Liquidity

ILAG has a Current Ratio of 6.39. This indicates that ILAG is financially healthy and has no problem in meeting its short term obligations.
ILAG has a better Current ratio (6.39) than 93.02% of its industry peers.
ILAG has a Quick Ratio of 4.05. This indicates that ILAG is financially healthy and has no problem in meeting its short term obligations.
ILAG's Quick ratio of 4.05 is amongst the best of the industry. ILAG outperforms 93.02% of its industry peers.
Industry RankSector Rank
Current Ratio 6.39
Quick Ratio 4.05

1

3. Growth

3.1 Past

The earnings per share for ILAG have decreased strongly by -176.30% in the last year.
The Revenue for ILAG has decreased by -29.13% in the past year. This is quite bad
The Revenue has been growing slightly by 2.99% on average over the past years.
EPS 1Y (TTM)-176.3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1106.96%
Revenue 1Y (TTM)-29.13%
Revenue growth 3Y2.99%
Revenue growth 5YN/A
Revenue growth Q2Q-73.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

ILAG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ILAG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTELLIGENT LIVING APPLICATI

NASDAQ:ILAG (5/2/2024, 3:14:43 PM)

After market: 0.551 -0.01 (-2.04%)

0.5625

0 (-0.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.16M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.4%
ROE -25.95%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 6.39
Quick Ratio 4.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-176.3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-29.13%
Revenue growth 3Y2.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y